Ya Xiao Selected Research

Ya Xiao Research Topics

Disease

5	Hypertension (High Blood Pressure) 09/2022 - 10/2018
5	Neoplasms (Cancer) 01/2022 - 04/2013
3	Wounds and Injuries (Trauma) 04/2015 - 01/2014
2	Fibrosis (Cirrhosis) 01/2021 - 01/2019
2	Stomach Neoplasms (Stomach Cancer) 07/2020 - 04/2009
2	Interstitial Cystitis (Interstitial Cystitis, Chronic) 01/2019 - 01/2017
2	Diabetes Mellitus 01/2018 - 01/2017
2	Prostatic Neoplasms (Prostate Cancer) 08/2017 - 11/2013
1	Hypercholesterolemia 09/2022
1	Dyslipidemias (Dyslipidemia) 09/2022
1	Dysbiosis 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Pain (Aches) 11/2021
1	Hyperthermia 01/2021
1	Rupture 11/2020
1	Glucose Intolerance 01/2020
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2020
1	Non-alcoholic Fatty Liver Disease 07/2019
1	Staghorn Calculi 07/2019
1	Fever (Fevers) 07/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2019
1	Burns 01/2019
1	Inflammation (Inflammations) 01/2019
1	Disease Progression 01/2019
1	Multiple Myeloma 01/2019
1	Coronary Disease (Coronary Heart Disease) 10/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2018
1	Liver Neoplasms (Liver Cancer) 08/2018
1	Hepatitis 08/2018
1	Chronic Hepatitis (Chronic Active Hepatitis) 08/2018
1	Cerebral Infarction 01/2018
1	Carotid Artery Diseases 01/2018
1	Reperfusion Injury 01/2018
1	Stroke (Strokes) 01/2018
1	Infections 01/2017
1	Vascular System Injuries 01/2017

Drug/Important Bio-Agent (IBA)

7	MicroRNAs (MicroRNA)IBA 01/2020 - 04/2013
4	Pharmaceutical PreparationsIBA 01/2021 - 08/2018
3	SaltsIBA 04/2021 - 01/2020
3	Messenger RNA (mRNA)IBA 04/2019 - 11/2013
3	Biomarkers (Surrogate Marker)IBA 01/2014 - 04/2013
2	Triglycerides (Triacylglycerol)IBA 09/2022 - 01/2018
2	CholesterolIBA 09/2022 - 01/2018
2	LipidsIBA 09/2022 - 01/2020
2	Activating Transcription Factor 4IBA 01/2021 - 01/2020
2	CreatinineIBA 01/2021 - 01/2013
2	CytokinesIBA 01/2019 - 12/2014
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 02/2015
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2013
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 11/2016
2	Angiotensin Receptor AntagonistsIBA 01/2013 - 12/2005
1	Particulate MatterIBA 09/2022
1	NitratesIBA 09/2022
1	MatrinesIBA 01/2022
1	armillaripinIBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	Transcription Factor CHOPIBA 04/2021
1	NitrogenIBA 01/2021
1	Vancomycin FDA LinkGeneric 01/2021
1	Serum AlbuminIBA 01/2021
1	16S Ribosomal RNAIBA 01/2021
1	Urea (Carbamide)FDA LinkGeneric 01/2021
1	Vitamin K 2 (Vitamin K2)IBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Liposomes (Liposome)IBA 11/2020
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 07/2020
1	Cisplatin (Platino)FDA LinkGeneric 07/2020
1	curcumolIBA 07/2020
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 07/2020
1	lycium barbarum polysaccharideIBA 01/2020
1	Hemoglobins (Hemoglobin)IBA 07/2019
1	RNA (Ribonucleic Acid)IBA 04/2019
1	Long Noncoding RNAIBA 04/2019
1	Competitive Endogenous RNAIBA 04/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	Interleukin-17 (Interleukin 17)IBA 01/2019
1	Janus KinasesIBA 01/2019
1	TriterpenesIBA 08/2018
1	cucurbitacin BIBA 08/2018
1	oxidized low density lipoproteinIBA 01/2018
1	naoxintongIBA 01/2018
1	Glycyrrhetinic Acid (Po 12)IBA 01/2018
1	puerarinIBA 01/2018
1	HDL CholesterolIBA 01/2018
1	LDL CholesterolIBA 01/2018
1	polyethylene glycol-b-poly(beta-benzyl aspartate)IBA 01/2018
1	Toll-Like Receptor 4IBA 01/2018
1	Capsules (Microcapsules)IBA 01/2018
1	Dihydrotestosterone (Androstanolone)IBA 08/2017
1	Uridine Diphosphate (UDP)IBA 08/2017
1	EnzymesIBA 08/2017
1	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 08/2017
1	AntigensIBA 01/2017

Therapy/Procedure

8	Therapeutics 01/2021 - 12/2005
3	Drug Therapy (Chemotherapy) 07/2020 - 04/2009
1	Stents 11/2021
1	Operative Time 07/2019
1	Percutaneous Nephrolithotomy 07/2019
1	Percutaneous Coronary Intervention 10/2018
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 10/2018